Johnson & Johnson
Trade Johnson & Johnson 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About JNJ
Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments.
JNJ Key Statistics
Stock Snapshot
As of today, Johnson & Johnson(JNJ) shares are valued at $222.72. The company's market cap stands at 536.63B, with a P/E ratio of 25.84 and a dividend yield of 2.3%.
On 2026-06-02, Johnson & Johnson(JNJ) stock traded between a low of $221.21 and a high of $225.50. Shares are currently priced at $222.72, which is +0.7% above the low and -1.2% below the high.
Johnson & Johnson(JNJ) shares are trading with a volume of 5.67M, against a daily average of 7.95M.
During the past year, Johnson & Johnson(JNJ) stock moved between $149.04 at its lowest and $251.71 at its peak.
During the past year, Johnson & Johnson(JNJ) stock moved between $149.04 at its lowest and $251.71 at its peak.
JNJ News
Medline’s (MDLN) shares dropped about 7% on Tuesday afternoon after the U.S. health watchdog issued a warning letter to the company — a medical supply rival to...
Despite its shares being in the red year to date, AbbVie's (ABBV +1.26%) financial results have been strong. The company's first-quarter update, released on Apr...
...
Analyst ratings
65%
of 26 ratingsMore JNJ News
Johnson & Johnson announced results from the final analysis of the Phase 3 Proteus study showing the investigational use of apalutamide plus hormone therapy, gi...
How to Build $12,500 a Month in Dividend Income From a $2.8 Million Portfolio Without Touching the Aggressive Tier By David Beren Published May 31, 1:41PM EDT...
Johnson & Johnson (JNJ) reported new clinical trial results showing that its experimental subcutaneous formulation of amivantamab produced durable responses in...
(RTTNews) - Johnson & Johnson (JNJ) announced results from the final analysis of the Phase 3 PROTEUS study, evaluating apalutamide plus hormone therapy (androge...
Key Points Recessions are a normal part of the economic cycle and can't be avoided. Investors can prepare for recessions by focusing on resilient sectors like...
The Two Bucket Income Portfolio That Pays $5,000 a Month Plus a Cash Reserve to Survive 2008 Style Drawdowns By Drew Wood Published May 30, 9:18AM EDT Quick R...
Johnson & Johnson announced updated results from the Phase 1/1b CHRYSALIS-2 study evaluating intravenous RYBREVANT in combination with LAZCLUZE in patients with...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.